A double-blind, placebo-controlled multicenter trial on the effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota
Latest Information Update: 08 Sep 2023
At a glance
- Drugs CTV 05 (Primary) ; Clindamycin
- Indications Bacterial vaginosis
- Focus Therapeutic Use
- 24 Aug 2023 Status changed from recruiting to completed.
- 05 Jul 2023 Planned End Date changed from 1 Jul 2022 to 1 Oct 2023.
- 05 Jul 2023 Planned primary completion date changed from 1 Jul 2022 to 1 Oct 2023.